Dr. Clément has 25+ years of experience in the field of Gene Therapy, with industry-leading expertise in adeno-associated virus (AAV) vector manufacturing.  At the Powell Gene Therapy Center of the University of Florida, Gainesville, she led AAV process development and manufacturing for R&D POC, IND-enabling Toxicology and IND studies, oversaw manufacturing and release of 10+ AAV INDs. Her research focused on developing scalable GMP-ready platforms using the HSV and the transfection systems in suspension. Dr. Clément joined National Resilience in 2021, as the PD Director, Viral Vaccines and Gene Therapy, where she oversaw multiple industry-sponsored manufacturing programs. She joined Siren Biotechnology in January 2022, a clinical-stage company focused on delivering a cure for cancer, where she leads manufacturing and CMC operations.